Level of Evidence for Labeled Dosing Recommendations in Renal Impairment

被引：0
|
作者：
Gagne, Joshua J.
Khan, Nazleen F.
Raj, Tara S.
Patel, Lajja R.
Choudhry, Niteesh K.
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
668
引用
收藏
页码：390 / 391
页数：2
相关论文
共 50 条
  • [1] Strength of evidence for labeled dosing recommendations in renal impairment
    Gagne, Joshua J.
    Khan, Nazleen F.
    Raj, Tara S.
    Patel, Lajja R.
    Choudhry, Niteesh K.
    CLINICAL TRIALS, 2017, 14 (02) : 219 - 221
  • [2] Dosing Recommendations for Pediatric Patients With Renal Impairment
    Al-Khouja, Amer
    Park, Kyunghun
    Anderson, Daijha J. C.
    Young, Caitlyn
    Wang, Jian
    Huang, Shiew Mei
    Khurana, Mona
    Burckart, Gilbert J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (12): : 1551 - 1560
  • [3] Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment
    Lathia, C
    Fleming, GF
    Meyer, M
    Ratain, MJ
    Whitfield, L
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 121 - 126
  • [4] Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment
    Chetan Lathia
    Gini F. Fleming
    Mark Meyer
    Mark J. Ratain
    Lloyd Whitfield
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 121 - 126
  • [5] Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment
    Brian P. Kearney
    Kitty Yale
    Jaymin Shah
    Lijie Zhong
    John F. Flaherty
    Clinical Pharmacokinetics, 2006, 45 : 1115 - 1124
  • [6] Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment
    Kearney, Brian P.
    Yale, Kitty
    Shah, Jaymin
    Zhong, Lijie
    Flaherty, John F.
    CLINICAL PHARMACOKINETICS, 2006, 45 (11) : 1115 - 1124
  • [7] Anticoagulant dosing in renal impairment
    Harder, S.
    PHLEBOLOGIE, 2015, 44 (06) : 316 - 319
  • [8] Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment
    Marra, Fiona
    Smolders, Elise J.
    El-Sherif, Omar
    Boyle, Alison
    Davidson, Katherine
    Sommerville, Andrew J.
    Marzolini, Catia
    Siccardi, Marco
    Burger, David
    Gibbons, Sara
    Khoo, Saye
    Back, David
    DRUGS IN R&D, 2021, 21 (01) : 9 - 27
  • [9] Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment
    Hariharan, Sudharshan
    Madabushi, Rajanikanth
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 : 119S - 125S
  • [10] Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment
    Fiona Marra
    Elise J. Smolders
    Omar El-Sherif
    Alison Boyle
    Katherine Davidson
    Andrew J. Sommerville
    Catia Marzolini
    Marco Siccardi
    David Burger
    Sara Gibbons
    Saye Khoo
    David Back
    Drugs in R&D, 2021, 21 : 9 - 27
12345